---
title: "BGM Group names Zhanchang Xin chairman after Chen Xin resigns"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294416013.md"
description: "BGM Group announced that Chen Xin resigned as Chairman and Co-CEO on July 30, 2026. His father, Zhanchang Xin, was appointed Chairman effective the same date, bringing over 35 years of pharmaceutical R&D experience. Additionally, Hong Li was named Co-CEO, leveraging her background as CFO since 2008."
datetime: "2026-07-30T21:04:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294416013.md)
  - [en](https://longbridge.com/en/news/294416013.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294416013.md)
generator: "portal-rs"
---

# BGM Group names Zhanchang Xin chairman after Chen Xin resigns

-   Chairman and Co-CEO Chen Xin resigned effective July 30, 2026 for personal reasons. \* Zhanchang Xin named chairman effective July 30, 2026; has led Gansu Qilianshan Pharmaceutical since 2006 with 35+ years in pharma R&D. \* Hong Li appointed co-CEO effective July 30, 2026; CFO of Gansu Qilianshan Pharmaceutical since 2008 with a finance and accounting background. \* Zhanchang Xin is Chen Xin’s father. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BGM Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-088690), on July 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [BGM.US](https://longbridge.com/en/quote/BGM.US.md)

## Related News & Research

- [BGM Group held extraordinary general meeting of shareholders](https://longbridge.com/en/news/298360799.md)
- [Amphastar Senior EVP Zhou Rong disposes of 3,187 common shares worth $75,294.94](https://longbridge.com/en/news/297968074.md)
- [Quantum Biopharma amends Form 6-K to add exhibit to F-3 registration statement](https://longbridge.com/en/news/298348186.md)
- [Contineum Therapeutics CEO Carmine N. Stengone disposes of 2,500 common shares for $41,141.5](https://longbridge.com/en/news/298370597.md)
- [Lemonade Chief Insurance Officer John Sheldon Peters reports disposal of 3,108 common shares worth $169,055.32](https://longbridge.com/en/news/298368795.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**